ÂÜÀòÂÒÂ×

Clifford Wong is an Associate Scientist at Tizona Therapeutics, Inc. since April 2017, specializing in assay development for CD39 program antibodies, recognized for pivotal contributions to partnership initiatives and data generation for IND submissions. Prior experience includes roles as Research Associate III at Dynavax Technologies and Perseid Therapeutics, where Clifford advanced clinical projects, developed liver failure models, and created in-vivo disease models. Additional roles at Maxygen/Perserid Therapeutics and Nektar Therapeutics involved PK/PD study designs, assay development, and regulatory compliance. Clifford holds a Bachelor's degree in Biological Sciences from the University of California, Davis and has completed a seminar in Immunology at the American Institute of Immunologists.